Speaker

Andrew Young

Chief Scientific & Medical Officer, I2O Therapeutics

Andrew Young, Chief Scientific & Medical Officer at I2O Therapeutics, is speaking at Amylin-Based Therapeutics Summit 2026 (Boston, United States of America, 1–3 Dec 2026) in the session “From Pancreatic Amyloid to Therapeutic Hormone: Lessons from the Discovery & Development of Amylin”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

Amylin-Based Therapeutics Summit 2026
1–3 Dec 2026Boston, United States of America
- SpeakerFrom Pancreatic Amyloid to Therapeutic Hormone: Lessons from the Discovery & Development of Amylin

More speakers at Amylin-Based Therapeutics Summit 2026

Daniel Briere
Senior Director, Eli Lilly
Debbie Hay
Professor, Pharmacology, Otago University
Thomas Lutz
Professor, University of Zurich
Cody Moore
Director, Platform Development, iBio
Augen Pioszak
Associate Professor, Department of Biochemistry & Physiology, University of Oklahoma
Kirsten Raun
Vice President, Scientific, Novo Nordisk

See all 9 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Andrew Young, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].